Evidence map›Paper›PMID 31342094›Full record

ReviewInflammation research : official journal of the European Histamine Research Society ... [et al.]2019

Potential of miRNAs to predict and treat inflammation from the perspective of Familial Mediterranean Fever.

Banu Balci-Peynircioglu, Yeliz Z Akkaya-Ulum, Tayfun Hilmi Akbaba, Zeynep Tavukcuoglu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Systemic autoinflammatory diseases.Journal of autoimmunity · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Banu Balci-PeynirciogluDepartment of Medical Biology, Hacettepe University, Ankara, Turkey. banupeynir@yahoo.com.ORCID http://orcid.org/0000-0002-8627-8796
Yeliz Z Akkaya-UlumDepartment of Medical Biology, Hacettepe University, Ankara, Turkey.
Tayfun Hilmi AkbabaDepartment of Medical Biology, Hacettepe University, Ankara, Turkey.
Zeynep TavukcuogluDepartment of Medical Biology, Hacettepe University, Ankara, Turkey.
Hacettepe University · TR

Funding

Hacettepe University 013D05101005TÜBİTAK 214S106
6 · The paper itself

Abstract

aimmicroRNAs (miRNAs) are small noncoding RNAs that play critical roles in physiological networks by regulating host genome expression at the post-transcriptional level. miRNAs are known to be key regulators of various biological processes in different types of immune cells, and they are known to regulate immunological functions. Differential expression of miRNAs has been documented in several diseases, including autoinflammatory and autoimmune diseases. This review aimed to focus on miRNAs and their association with autoimmune and autoinflammatory diseases.

methodsAll related literature was screened from PubMed, and we discussed the possible role of miRNAs in disease prediction and usage as therapeutic agents from the perspective of Familial Mediterranean Fever (FMF).

conclusionsFMF is an inherited autosomal recessive autoinflammatory disease caused by mutations in the MEditerranean FeVer (MEFV) gene, which encodes the protein pyrin. Recent studies have demonstrated that miRNAs may be effective in the pathogenesis of FMF and offer a potential explanation for phenotypic heterogeneity. Further understanding of the role of miRNAs in the pathogenesis of these diseases may help to identify molecular diagnostic markers, which may be important for the differential diagnosis of autoinflammatory diseases. Studies have shown that in the near future, traditional therapies in autoinflammatory diseases may be replaced with novel effective, miRNA-based therapies, such as the delivery of miRNA mimics or antagonists. These approaches may be important for predictive, preventive, and personalized medicine.

Indexed as

MicroRNAsAnimalsFamilial Mediterranean FeverHumansImmune System DiseasesInflammationMicroRNAsAutoinflammatory diseasesFamilial Mediterranean FevermicroRNAs

Identifiers

PMID31342094
OpenAlexW2963891641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.